LAKE ZURICH, Ill.--(BUSINESS WIRE)--The U.S. Food and Drug Administration has cleared Fenwal to market a therapeutic plasma exchange protocol for the company’s Amicus® separator, Fenwal announced today.
LAKE ZURICH, Ill.--(BUSINESS WIRE)--The U.S. Food and Drug Administration has cleared Fenwal to market a therapeutic plasma exchange protocol for the company’s Amicus® separator, Fenwal announced today.
